PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29167164-1	2018	Nuclear factor erythyroid factor 2 (Nrf2) transcribes genes in cultured endothelial cells that reduce reactive oxygen species (ROS) and generate nitric oxide (NO) or metabolize asymmetric dimethylarginine (ADMA), which inhibits NO synthase (NOS).	dimethylarginine	188-204	nitric oxide synthase 1, neuronal	Mus musculus	228-239	
32238672-1	2020	Dimethylarginine dimethylaminohydrolase-1 (DDAH1) maintains nitric oxide (NO) bioavailability by degrading asymmetric dimethylarginine (ADMA), which is an endogenous inhibitor of nitric oxide synthase (NOS).	dimethylarginine	118-134	nitric oxide synthase 1, neuronal	Mus musculus	179-200	
34310708-1	2021	Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase (NOS) inhibitor/uncoupler inducing vascular pathology.	dimethylarginine	11-27	nitric oxide synthase 1, neuronal	Mus musculus	52-73	
26806551-1	2016	Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is degraded by dimethylarginine dimethylaminohydrolase 1 (DDAH1).	dimethylarginine	11-27	nitric oxide synthase 1, neuronal	Mus musculus	50-71	
24690995-1	2014	The purpose of the work was to study the impact of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA) and its degrading enzyme, dimethylarginine dimethylaminohydrolase (DDAH1), on atherosclerosis in subtotally nephrectomized (SNX) ApoE-deficient mice.	dimethylarginine	115-131	nitric oxide synthase 1, neuronal	Mus musculus	66-87	
25913572-1	2015	There is increasing evidence that the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethyl-arginine (ADMA) is involved in the pathogenesis of chronic lung diseases.	dimethylarginine	98-115	nitric oxide synthase 1, neuronal	Mus musculus	49-70	
25786132-3	2015	We have previously reported that LPS-mediated nitric oxide synthase (NOS) uncoupling, through increases in asymmetric dimethylarginine (ADMA), plays an important role in the development of ALI through the generation of reactive oxygen and nitrogen species.	dimethylarginine	118-134	nitric oxide synthase 1, neuronal	Mus musculus	46-67	
21719758-1	2011	RATIONALE: Asymmetric dimethylarginine (ADMA) is an endogenous nitric oxide synthase (NOS) inhibitor that competes with L-arginine for binding to NOS.	dimethylarginine	22-38	nitric oxide synthase 1, neuronal	Mus musculus	63-84	
20845411-1	2011	Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase (NOS) inhibitor, is accumulated in plasma during chronic kidney disease (CKD).	dimethylarginine	11-27	nitric oxide synthase 1, neuronal	Mus musculus	50-71	
20558777-1	2011	Altered arginine metabolism, the uncoupling of nitric oxide synthase (NOS) by asymmetric dimethyl-arginine (ADMA), increased oxo-nitrosative stress, and cellular injury were reported in airway epithelial cells in asthma.	dimethylarginine	89-106	nitric oxide synthase 1, neuronal	Mus musculus	47-68	
21756303-2	2011	Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), plays a pivotal role in endothelial dysfunction.	dimethylarginine	11-27	nitric oxide synthase 1, neuronal	Mus musculus	63-84	
18063827-1	2008	BACKGROUND AND PURPOSE: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS).	dimethylarginine	35-51	nitric oxide synthase 1, neuronal	Mus musculus	89-110	
19648472-1	2010	Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), causes uncoupling of NOS leading to generation of reactive nitrogen species, such as peroxynitrite.	dimethylarginine	11-27	nitric oxide synthase 1, neuronal	Mus musculus	63-84	
18239148-2	2008	Asymmetrical dimethylarginine (ADMA) is an endogenous inhibitor of NO synthase (NOS).	dimethylarginine	13-29	nitric oxide synthase 1, neuronal	Mus musculus	67-78	
15920994-2	2005	Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of NO synthase (NOS).	dimethylarginine	11-27	nitric oxide synthase 1, neuronal	Mus musculus	65-76	
17349891-2	2007	BACKGROUND: Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS).	dimethylarginine	23-39	nitric oxide synthase 1, neuronal	Mus musculus	70-91	
15781754-1	2005	BACKGROUND: This study was designed to determine whether overexpression of the enzyme dimethylarginine dimethylaminohydrolase (DDAH) could enhance angiogenesis by reducing levels of the endogenous nitric oxide synthase (NOS) inhibitor asymmetric dimethylarginine (ADMA).	dimethylarginine	86-102	nitric oxide synthase 1, neuronal	Mus musculus	197-218	
11703587-1	2001	BACKGROUND: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase (NOS) that accumulates in renal insufficiency and may be a uremic toxin.	dimethylarginine	23-39	nitric oxide synthase 1, neuronal	Mus musculus	77-98